Kidney Transplant Infection
40
5
9
15
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 42/100
7.5%
3 terminated out of 40 trials
83.3%
-3.2% vs benchmark
30%
12 trials in Phase 3/4
20%
3 of 15 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 15 completed trials
Clinical Trials (40)
Letermovir (Prevymis) for CMV in Kidney and Pancreas Transplant Recipients
A Trial to Treat Polyomavirus Infections (BKPyV) in Kidney and Simultaneous Kidney Pancreas Transplant Recipients
The Efficacy of Everolimus With Reduced-dose Tacrolimus Versus Reduced-dose Tacrolimus and Leflunomide in Treatment of BK Virus Infection in Kidney Transplantation Recipient
Evolution of CMV Antiviral T-cell Immunity Over the Next Six Months Initiation of Treatment With Belatacept.
Secondary Prophylaxis After CMV Disease in Kidney Transplant Patients Targeted by γδ T Cells Immunomonitoring.
Immune Monitoring of Prevalent Kidney Transplant Recipients Using Torque Teno Virus: A Single-Center, Prospective Cohort Study
Reduction of BK Viremia in Kidney Transplant Patients
CMV T Cell Immunity in Pediatric Solid Organ Transplant Recipients
Prevalence of BK Viremia in Simultaneous Liver-Kidney Transplant
Effectiveness of an Immune-guided Cytomegalovirus Infection Preventive Strategy Compared to a Universal Prophylactic Strategy in Renal Transplant Patients
Prediction and Prevention of Bloodstream Infections After Kidney Transplantation
Prediction of BK Virus Reactivation in Kidney Transplant Recipient
Early vs Late Urinary Catheter Removal After Renal Transplantation
PRObiotics for KIdney Transplantation
BK With VST for Kidney Transplant Patients
SARS-COV-2 Infection in Kidney Transplant Recipients: a Brazilian Multicenter Study
Anti-Viral Effects of Voclosporin in COVID-19 Positive Kidney Transplant Recipients
Efficacy of 7 Days Versus 14 Days of Antibiotic Therapy for Acute Pyelonephritis in Kidney Transplant Recipients, a Multicentre Randomized Non-inferiority Trial.
Immunogenicity of HPV Vaccine in Immunosuppressed Children
Use of Wearables to Detect Infections in Kidney Transplant Recipients